Monday, 21st September Bio-Pharma & HealthTech:

Monday, 21st September Bio-Pharma & HealthTech: Pandemic Response Day Time Zone - CET.13:00Virtual Event – Day 1 Opens13:20Welcome SpeechVaccines PanelChaired by:Thomas Shrader, Managing Director & Healthcare Analyst, BTIG, LLC13:25Panelists:Andrei Floroiu, President & CEO, Vaxart, Inc.Andrew Allen, Co-Founder, President & CEO, Gritstone Oncology, Inc.Frederic Ors, CEO, IMV Inc.Johan Van Hoof, Global Therapeutic Area Head of Infectious Diseases & Vaccines and Managing Director, Janssen Vaccines & Prevention B.V.Spotlight Showcases14:25Vaxart, Inc.14:45KEYNOTE: “Mobilizing a Response to COVID” by Mark Stevenson, Executive Vice President & Chief Operating Officer, Thermo Fisher ScientificModerated by: Mike Ward, Global Head of Thought Leadership, Decision Resources, Inc.15:15KEYNOTE: “Thinking a Few Steps Ahead: Developing Covid Products for Beyond the Pandemic”by Peter Kolchinsky, Co-Founder & Managing Partner, RA Capital Management, L.P.Moderated by: Mike Ward, Global Head of Thought Leadership, Decision Resources, Inc.15:5011:00AMBreakKEYNOTE: “The Miracle of VIP: How The Son of a Coptic Cleric May Rescue Humanity From COVID-19”by Jonathan Javitt, Chairman & CEO, NeuroRx, Inc.16:00Therapeutic Strategies to Prevent & Treat Covid-19 PanelCo-Chaired by:Max Herrmann, Managing Director, Stifel Financial Corp.Rao Movva, Novartis Distinguished Scientist & Independent Pharma & Biotech Advisor16:20Panelists:Dave Hallett, COO, Exscientia Ltd.Edward Littler, Founder, Collaborative Community against Coronavirus (3C)Gilead Raday, COO, RedHill Biopharma Ltd.Richard Marsden, CEO, Synairgen Research LimitedPoint of Care Diagnostics PanelCo-Chaired by:Rainer Strohmenger, Managing Partner, Wellington PartnersSilvio Belletti, Managing Director & Partner, Boston Consulting Group17:00Panelists:Achim Plum, Managing Director & CCO, SphingoTec GmbHChristoph Pedain, Head of Point of Care, Siemens Healthineers AGMartin Potgeter, Vice President, Corporate Business Development, QIAGEN GmbHRainer Metzger, Head of Integrated Clinical Services, Medicover AB15:0018:00Spotlight Showcase:Showcase SphingoTec GmbH18:20End of Day 111:00 AMGold Sponsor:Silver Sponsors:Bronze Sponsors:Contributing Sponsors:

Tuesday, 22nd September BioTech & HealthTech Capital Investment Day Time Zone - CET.10:00Virtual Event – Day 2 Opens10:30Welcome Speech by Samuel Hess, Head of Economics, Office of Economy and Labor, Canton of Basel StadtBio-Pharma in a New Era PanelChaired by:Stephanie Léouzon, Partner & Head of Europe,Torreya Partners LLP10:50Panelists:Chandra Leo, Investment Advisor, HBM Partners AGGil Bar-Nahum, Managing Director, EMEA Head of Biotechnology, Jefferies International Ltd.Kieran Rooney, VP, Strategic Alliances & Licensing, Amryt Pharma PlcSam Fazeli, Head of Research, Senior Pharmaceuticals Analyst, Bloomberg IntelligenceYves Wyckmans, Sr. Dir. Corporate & BD, Licensing Transactions and M&A, Actelion, a Janssen Pharmaceuticals Company of Johnson & JohnsonAccessing US Capital Markets from Europe PanelChaired by:Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors11:50Panelists:Frédéric Cren, CEO, Inventiva PharmaIsabella Schidrich, Senior Managing Director, NasdaqNicholas Moore, Managing Director, Healthcare Investment Banking, Stifel Financial Corp.Nissim Darvish, Senior Managing Director, OrbiMed Advisors LLCRenee Aguiar-Lucander, CEO, Calliditas Therapeutics ABShayne Kennedy, Partner, Latham & Watkins LLPIPO Bootcamp: “The IPO Process & the Secrets to Successful Execution”Chaired by:Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors12:50Panelists:Filippo Petti, CEO, Celyad Oncology SAJordan Saxe, Global Head of Healthcare, NasdaqMichael Rice, Founding Partner, LifeSci AdvisorsNathan Ajiashvili, Partner, Latham & Watkins LLPNicholas Moore, Managing Director, Healthcare Investment Banking, Stifel Financial Corp.Revolution in Cell Based Therapies Across Therapeutics PanelCo-Chaired by:Alain Vertès, Managing Director, NxR Biotechnologies GmbHAlberto Santagostino, SVP, Head of Cell & Gene Technologies, Lonza AG13:50Panelists:Miguel Forte, CEO, Bone Therapeutics SAReagan Jarvis, Co-Founder & CEO, Anocca ABRegina Hodits, Managing Partner, Wellington PartnersSteven Kelly, President & CEO, Carisma Therapeutics Inc.Gold Sponsor:Silver Sponsors:Bronze Sponsors:Contributing Sponsors:

Tuesday, 22nd September BioTech & HealthTech Capital Investment Day Time Zone - CET.Spotlight Showcases14:50Anocca AB15:10Bone Therapeutics SA15:30Break15:40KEYNOTE: ”Supporting Best-in-Class European Innovation and Tackling the Covid-19 Crisis”by Kurt Höller, Director of Business Creation, EIT Health e.V.VC & Private Equity: Addressing All Opportunities, Including Crossover Transactions PanelCo-Chaired by:Hubert Birner, Managing Partner, TVM Life Science Management GmbHMarkus Hosang, General Partner, BioMedPartners AGPanelists:Anja König, Global Head, Novartis Venture FundDennis Purcell, Founder, Aisling Capital LLCGiovanni Mariggi, Partner, MedicxiNanna Luneborg, Partner, Novo VenturesSøren Bjønness, Director – Switzerland Representative, Euronext Paris S.A.Vanela Bushi, Director, Portfolio Strategy & Transactions, Syneos Health, LLC16:00Spotlight Showcases17:00Euronext Paris S.A.17:20Syneos Health, LLC17:40Amazon Web Services EMEA SARLEarly Stage Investment PanelCo-Chaired by:Bibhash Mukhopadhyay, Principal, New Enterprise Associates (NEA)Søren Møller, Managing Partner, Novo Seeds, Novo Holdings A/SPanelists:Guy Spigelman, EMEA Lead, Healthcare & Life Sciences Startups, Amazon Web Services EMEA SARLJoy Cürten, Head of Accelerator, EIT Health e.V.Karen Wagner, Managing Partner, Ysios CapitalLior Teitelbaum, CBO, FutuRx Ltd.Michael Altorfer, CEO, Swiss Biotech AssociationThijs Cohen Tervaert, Director, INKEF Capital BV18:0019:0011:00AMEnd of Day 2Gold Sponsor:Silver Sponsors:Bronze Sponsors:Contributing Sponsors:

Wednesday, 23rd September Bio-Pharma Partnering & Therapeutics Day Time Zone - CET.Virtual Event – Day 3 Opens10:00Pharma DealMaking PanelCo-Chaired by:Jeffrey Bockman, EVP, Oncology Practice Head, Cello Health BioConsultingPeter Sandor, SVP, PFL Oncology, Astellas Pharma, Inc.Panelists:Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing, Novartis International AGNiels Emmerich, VP, Global Head Search & Evaluation, AbbVie, Inc.Philippe Lopes-Fernandes, SVP, Global Head of Business Development & Alliance Management, MerckRichard Ward, Director, Search & Evaluation, AstraZenecaSusanna Obad, Director, Business Development, F. Hoffmann-La Roche Ltd.10:20Immuno-Oncology BD&L PanelCo-Chaired by:Katya Smirnyagina, Executive Director, Capricorn Partners NVMatthias Müllenbeck, Executive Director & Head Global Licensing & BD Enabling Technologies, Merck KGaA11:20Panelists:Corinne Venot, Senior Director, Business Development, BeiGene Ltd.François Thomas, Venture Partner, Inserm Transfert Initiative/SofimacKhatereh Ahmadi, Executive Director, Oncology Search & Evaluation Lead for Europe, MSDRichard Godfrey, CEO, BerGenBio ASASpotlight Showcases12:20BeiGene Ltd.12:40MSD13:00BerGenBio ASA13:2011:00AMBreakAdvanced Therapies in Immuno-Oncology PanelCo-Chaired by:Esteban Pombo-Villar, CEO, TargImmune Therapeutics AGMichael Rice, Principal, Head of Advanced Therapeutics, Cello Health BioConsulting13:40Panelists:Erik Manting, CEO, DCPrime B.V.Jürgen Gamer, VP BD, Apogenix AGMelissa McCracken, Principal, Nextech Invest Ltd.Sébastien Petitet, CCO, Brenus PharmaSijme Zeilemaker, COO, Immunicum ABTed Fjällman, CEO, Prokarium Ltd.Spotlight Showcases14:40Spotlight Showcase:Showcase Immunicum ABImmunicum AB15:00TollysGold Sponsor:Silver Sponsors:Bronze Sponsors:Contributing Sponsors:

Wednesday, 23rd September Bio-Pharma Partnering & Therapeutics Day Time Zone - CET.KEYNOTE: “Health-Tech Convergence: Israel Next Big Growth Engine – A New Perspective with Gulf Countries”by Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences15:20‘’Exciting Opportunities in Krakow, Poland – Life Science is Growing Here’’ WorkshopChaired by:Justyna Czyszek, Investor Services Manager, Krakowski Park Technologiczny sp. z o.o.15:40Panelists:Edyta Jaworska, Integrated Drug Discovery Director & Management Board Member, Selvita S.A.Leszek Skowron, Life Science Investment Director, INNOventure Sp. z o.o.Piotr Stępniak, Director of Immunology, Ardigen S.A.Platform Technologies & Novel Therapeutics PanelCo-Chaired by:Eric de La Fortelle, Venture Partner, Seventure PartnersHolger Reithinger, General Partner, Forbion16:10Panelists:Anne Altmeyer, Chief Business Officer, Sigilon Therapeutics, Inc.Joachim Vogt, Director Search & Evaluation Western Europe, AbbVie Deutschland GmbH Co. KGLynn Durham, Founder & CEO, STALICLA S.A.Mike Romanos, Co-Founder & CEO, Microbiotica Ltd.Ross Muken, CFO, Click Therapeutics, Inc.Spotlight Showcase17:10STALICLA S.A.17:3011:00AMEnd of Day 3Gold Sponsor:Silver Sponsors:Bronze Sponsors:Contributing Sponsors:

Thursday, 24th September Neuroscience Investor Day Time Zone - CET.Virtual Event – Day 4 Opens12:30CNS Partnering & DealMaking PanelCo-Chaired by:Lubor Gaal, SVP, Head of Europe, Locust WalkTim Luker, VP, Search & Evaluation – Emerging Technology & Innovation, Corporate BD, Eli Lilly and Company12:50Panelists:Alexander Breidenbach, Founder/Entrepreneur-in-Residence, KetteRx GmbH/BB Pureos BioventuresAnna Lisa Picciolo-Lehrke, Head Business Development Neurology, UCB PharmaShafique Virani, Chief Corporate Development Officer, Recursion PharmaceuticalsStuart Barich, Managing Director, Life Sciences Investment Banking, Raymond JamesProgress in AD & PD PanelCo-Chaired by:Patrick Benz, Sr. Director Alliance Management, The Janssen Pharmaceutical Companies of Johnson & JohnsonSumant Kulkarni, Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC13:50Panelists:Christian Jung, Partner, Dementia Discovery FundErik Buntinx, Founding CEO/Inventor, ANeuroTechRoger Bullock, CMO, Oryzon Genomics S.A.Scott Shandler, CEO, Longevity Biotech, Inc.Susan Kohlhaas, Director of Research, Alzheimer's Research UKAdvanced Therapeutics PanelCo-Chaired by:Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, AbbVie, Inc.Paul Matteis, Managing Director, Co-Head of Biotech Research, Stifel Financial Corp.14:50Panelists:Manuel López-Figueroa, Scientific Liaison, Pritzker Neuropsychiatric Disorders Research ConsortiumMark Altmeyer, President & CEO, Arvelle TherapeuticsMichael Scherz, Founder & CEO, Metys Pharmaceuticals AGParag Meswani, SVP, Commercial Strategy & Operations, Axovant Gene TherapiesSander van Deventer, Operating Partner, Forbion15:5011:00AM16:05BreakKEYNOTE: “The Global Neurotech Device Market: The Emergence of Bioelectronic Medicine”by James Cavuoto, Editor & Publisher, Neurotech ReportsAdvances in Neurotech, Software & Diagnostics PanelChaired by:Maciek Drozdz, Advisor, Polish Center for Technology Development16:20Panelists:Andy Blackwell, CSO, Ieso Digital HealthDavid Gordon, Head of Investments, Longliv Ventures, a member of CK Hutchison HoldingsDiana Saraceni, Co-Founder & Managing Partner, Panakès Partners SGR SpASusanne Wilke, President & CEO, Cognoptix, Inc.17:00Spotlight Showcase: Cognoptix, Inc.Gold Sponsor:Silver Sponsors:Bronze Sponsors:Contributing Sponsors: